Kesha Kelly, NP
Women's Health · Indianapolis, INNPI 1205094000
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,649 of the $3,823 with a category attached, or 69.3%. 27 manufacturers reported payments, led by Pfizer at 31.1% of the total. Reporting peaked in 2022 at $1,769 and has fallen 91.9% since, to $143 in 2025. Among women's health clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 149 payments — averaging $25.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$1K
- AbbVie$680
- Hologic Sales And Service, LLC$222
- Mayne Pharma Commercial LLC$192
- Sumitomo Pharma America, Inc.$168
- Exeltis, USA Inc.$162
- plus $1K from 21 others
What the payments were for
- Consulting fees$1,08028%
- Food & beverage$2,64969%
- Education$942%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 8 | $1,189 |
| AbbVie | 42 | $680 |
| Hologic Sales And Service, LLC | 8 | $222 |
| Mayne Pharma Commercial LLC | 9 | $192 |
| Sumitomo Pharma America, Inc. | 9 | $168 |
| Exeltis, USA Inc. | 11 | $162 |
| Myovant Sciences Inc. | 8 | $152 |
| Astellas Pharma US Inc | 3 | $121 |
| Biogen | 5 | $113 |
| Bayer | 6 | $105 |
| Coopersurgical, Inc. | 5 | $102 |
| Therapeuticsmd, Inc. | 5 | $73 |
| Avion Pharmaceuticals | 5 | $68 |
| Agile Therapeutics, Inc. | 3 | $60 |
| Novo Nordisk | 4 | $58 |
| Organon | 2 | $57 |
| Millicent US Inc | 3 | $53 |
| Shield Therapeutics Inc | 2 | $43 |
| Exact Sciences | 2 | $41 |
| Merck | 2 | $36 |
| Kerecis Limited | 1 | $24 |
| BD | 1 | $20 |
| Smith+Nephew | 1 | $20 |
| Aspira Women's Health Inc | 1 | $18 |
| Axonics, Inc. | 1 | $18 |
| Hologic Inc | 1 | $18 |
| Lilly USA, LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MYFEMBREE$1,080
How this compares
$3,823 in reported general payments places this provider in the 95th percentile of 142 women's health providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 56 | $3,848 |
| YuvafemEstradiol | 11 | $1,599 |
| ProgesteroneProgesterone, Micronized | 14 | $436 |
| Levothyroxine Sodium | 30 | $186 |
| Atorvastatin Calcium | 18 | $157 |
| Alendronate Sodium | 12 | $139 |
Paid to pharmacies, not to this prescriber.
Other women's health in Indianapolis
- Cara RaunickIndianapolis$73K
- Courtney CortezIndianapolis$5K
- Lara NaanouhIndianapolis$2K
- Susan LogsdonIndianapolis$2K
- Lisa Chan OwensbyIndianapolis$1K
- Ninya WilkersonIndianapolis$687
- Jennifer BrownIndianapolis$672
- Kara MortonIndianapolis$622
- Lauren ThorntonIndianapolis$570
- Jordan RamirezIndianapolis$561
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.